# A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function

> **NCT00956306** · PHASE1 · COMPLETED · sponsor: **Dong-A Pharmaceutical Co., Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** Udenafil

## Key facts

- **NCT ID:** NCT00956306
- **Lead sponsor:** Dong-A Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956306, "A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00956306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*